UPDATE: Citigroup Raises PT to $102 on McKesson

Citigroup increases its price target to $102 on Buy-rated McKesson MCK on delays of a VA contract that keeps the company servicing while a potential repricing may provide additional upside. Citigroup says, "The Veterans Affairs (VA) contract that was expected to be announced this week appears to be delayed until at least mid-April. Buy-rated McKesson is the primary pharmaceutical vendor on the ~$4.3B contract and has serviced the contract since 2004. Given that a contract switch would likely require ~90 days for a new vendor to implement, we suspect that McKesson will service the contact for a meaningful period beyond the scheduled May 9, 2012 termination date, causing us to raise our estimates as any repricing of the contract, or a potential contract loss, gets pushed out." MCK closed at $88.59 a share yesterday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorPrice TargetReiterationPre-Market OutlookAnalyst RatingsCitigroupHealth CareHealth Care Distributors
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!